2011
DOI: 10.1002/jbm.b.31894
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic effect of resveratrol and quercetin released from drug‐eluting polymer coatings for endovascular devices

Abstract: This study describes the development and evaluation of novel polymer films that provide controlled release of two vascular-protective polyphenols for endovascular devices. Resveratrol (RESV) and quercetin (QUER) have antimigratory and antiproliferative actions on vascular smooth muscle cells (VSMCs), inhibit both platelet and inflammatory cell activation, and promote endothelial cell function. Our aim is to develop and characterize coatings that release these drugs within a therapeutic range. The most synergis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 29 publications
0
15
0
Order By: Relevance
“…The study conducted by Kleinedler et al 24 describes the development and evaluation of polymers that provide a release of vascular-protective polyphenols for endovascular devices. RES combined with querencin was incorporated into an arborescent poly(styrene-isobutylene-styrene) tri-block polymer (arbIBS) and applied to stainless steel coupons using an electrospray process.…”
Section: Discussionmentioning
confidence: 99%
“…The study conducted by Kleinedler et al 24 describes the development and evaluation of polymers that provide a release of vascular-protective polyphenols for endovascular devices. RES combined with querencin was incorporated into an arborescent poly(styrene-isobutylene-styrene) tri-block polymer (arbIBS) and applied to stainless steel coupons using an electrospray process.…”
Section: Discussionmentioning
confidence: 99%
“…Other cardioprotective effects of resveratrol include inhibition of vascular smooth muscle cell proliferation 152,153 , which has therapeutic relevance for the treatment and/or prevention of pulmonary hypertension 131 and neointima formation 129 . On the basis of the synergistic inhibitory effects of resveratrol on vascular smooth muscle cell proliferation, macrophage activation and platelet stimulation, the use of resveratrol-eluting coatings for the prevention of in-stent stenosis is being considered 154 .…”
Section: Sirt1 Resveratrol and Diseasementioning
confidence: 99%
“…To combat restenosis, for example, compounds inhibiting VSMC proliferation are of interest for local application in drug-eluting stents, and the usage of combinations of synergistically interacting components might lead to a superior treatment outcome. Another study further demonstrating the potential of such a synergistic treatment approach has been recently performed with a combined resveratrol and quercetin formulation incorporated into drug-eluting polymer coatings with possible future application in the prevention of in-stent restenosis [35].…”
mentioning
confidence: 99%